| 作者・相关律师 | |
|---|---|
| 发行年月日 | 2026年2月 |
| 业务领域 | |
| 行业领域 | 食品·饮料医疗、医药、保健、生命科学和生物技术化学 |
时事通讯 "Life Science(2026年2月)发布。
Contents
I. Revision of the “Guidelines to Be Observed by Distribution-Related Parties for the Improvement of Distribution of Prescription Drugs”
- Background to the Revision of the Guidelines
- Contents of the Draft Revision
II. Publication of the “Recommendations on Intractable and Rare Diseases Based on a Survey of Challenges Faced by Healthcare Professionals”
- Issues and Recommendations Regarding Disease Awareness and Information Provision to Patients
- Issues and Recommendations Regarding Strengthening Early Diagnosis Systems
- Issues and Recommendations Regarding Accelerating Research and Development
- Other Issues and Recommendations